testosterone researchShilajit Benefits for Men: Testosterone, Energy and What the Research Shows

In a 2016 randomized double-blind trial published in Andrologia, healthy men aged 45 to 55 took 500 mg of purified shilajit daily for 90 days. By the end of the study, total testosterone, free testosterone, and DHEAS had all increased significantly compared to the placebo group. The effect was real. The research is legitimate. And almost every supplement company selling shilajit has made sure you see exactly this — while skipping the parts that would help you determine whether you're in the population that benefits.

Three things separate men who will see meaningful results from shilajit from men who will spend three months and $200 on a supplement that does nothing measurable. First: which of the three distinct mechanisms you're actually activating. Second: whether your hormonal and metabolic baseline puts you in the responder group. Third: whether the product you bought is even close in quality to what was used in the clinical trials.

This is the breakdown that answers all three.

Three Mechanisms, Three Different Outcomes#

Most coverage of shilajit treats it as a single testosterone supplement. It isn't. Shilajit is a phytocomplex — a resinous mineral deposit formed over centuries from decomposed plant matter in high-altitude mountain rock — and its bioactivity comes from three chemically distinct components that work through different biological pathways.

Fulvic acid (FA) makes up the bulk of standardized shilajit extracts — typically 50–57% by weight in high-quality preparations. This is the component most relevant to testosterone. Fulvic acid stimulates gonadotropin release at the level of the pituitary, increasing FSH (follicle-stimulating hormone) and LH (luteinizing hormone) secretion. LH acts directly on Leydig cells in the testes, which are the primary site of testosterone synthesis. Higher LH → greater stimulus for Leydig cells → more testosterone produced. Fulvic acid also appears to modulate SHBG (sex hormone-binding globulin) downward, which increases the free testosterone fraction even when total T changes are modest.

Dibenzo-alpha-pyrones (DBPs) are present in much smaller quantities (approximately 0.4–0.5% in standardized extracts), but they're the component that explains shilajit's consistent reputation for improving energy and physical recovery in populations where testosterone changes are minimal. DBPs interact with the mitochondrial electron transport chain at Complexes I and II. The result is improved efficiency of ATP synthesis — more energy output per unit of substrate. In animal models, 3-hydroxydibenzo-alpha-pyrone specifically increased ATP content and the ATP/ADP ratio in cells under metabolic stress. This is not a placebo-driven "energy feeling." It is mitochondrial bioenergetics at the molecular level.

Trace mineral chelation is the third pathway, and the least likely to be a direct performance variable for most men — but it matters for understanding why certain stacks make sense. Fulvic acid chelates minerals, improving their bioavailability and transporting them across cell membranes. This is particularly relevant for zinc, which is the rate-limiting cofactor for testosterone synthesis in Leydig cells. It's part of the mechanistic rationale for combining shilajit with zinc.

These three pathways explain a pattern that confuses most users: men who try shilajit sometimes see testosterone changes, sometimes see energy improvements without meaningful T changes, and sometimes see both. The outcome depends on which mechanism is most capacity-constrained in that individual's biology — not on a single universal "testosterone booster" effect.

What Two Clinical Trials Actually Show#

There are two meaningful human trials on shilajit, both published in Andrologia, both involving supplementation for 90 days, and both with important limitations that are almost universally ignored in supplement marketing.

The 2016 Pandit trial is the testosterone study. Healthy male volunteers aged 45 to 55 took 250 mg of purified shilajit twice daily (500 mg/day total) for 90 consecutive days in a randomized, double-blind, placebo-controlled design. Total testosterone, free testosterone, and DHEAS all increased significantly versus placebo by the end of the 90-day period. The effect is real.

The critical limitation: the study enrolled men in their late 40s and early 50s — a population experiencing natural age-related hormonal decline and where baseline LH stimulation may already be suboptimal. This does not mean the effect doesn't exist in younger men, but it does mean the 2016 data doesn't prove it exists. Men in their late 30s or 40s with declining testosterone are more likely to see results. Men in their mid-20s with high-normal testosterone are not in the studied population and shouldn't assume equivalent benefit.

The earlier spermatogenic trial enrolled 35 oligospermic men — men with documented sperm counts below 20 million per milliliter — who received 100 mg of processed shilajit twice daily (200 mg/day) for 90 days. By the end of the study, total sperm count had increased by 61.4%, sperm motility had improved meaningfully, and normal sperm morphology increased by 18.9%. This is a disease-context trial (infertility), which limits extrapolation to healthy men, but it confirms that shilajit has biologically meaningful effects on male reproductive function at a lower dose than the testosterone trial.

Neither study is large. Neither has been independently replicated in a high-powered multi-center trial. The evidence base is real but preliminary by evidence hierarchy standards. Shilajit has a plausible mechanism, two supporting human trials, and a long history of traditional Ayurvedic use — that's a reasonable foundation for supplementation, not a proven pharmaceutical-grade effect.

Who Benefits Most — and Who Won't See Much#

The testosterone pathway through fulvic acid and FSH/LH stimulation has one important feature: it works best when the HPG (hypothalamic-pituitary-gonadal) axis has room to increase output. If your LH is already firing at high capacity and your testosterone is at the high end of the normal range, adding more FSH/LH stimulus doesn't produce a proportional T increase. The Leydig cells can only do so much.

Men most likely to see measurable testosterone improvements:

• Men aged 35–55 with sub-optimal total testosterone (mid-to-low-normal range, roughly 350–500 ng/dL)
• Men with chronically elevated cortisol from high-stress lifestyles or overtraining — cortisol suppresses LH secretion at the hypothalamic level, and anything that reduces this suppression (including improved stress axis function from the DBP-mitochondrial pathway) can free up LH output
• Men with low zinc status — the mineral chelation pathway increases zinc bioavailability, which is directly rate-limiting for Leydig cell synthesis

Men least likely to see meaningful testosterone changes:

• Men with high-normal or optimal total testosterone (above 600 ng/dL) with normal SHBG — there's less headroom for the FSH/LH pathway to drive further increases
• Young men (under 30) with fully optimized testosterone and no hormonal dysfunction
• Men seeking a substitute for TRT — shilajit is not a therapeutic equivalent; it supports a healthy HPG axis, it does not replace a suppressed or malfunctioning one

The mitochondrial energy effect from DBPs, by contrast, is likely more broadly applicable. Mitochondrial efficiency declines with age, overtraining, and chronic caloric stress. Men who train regularly and deal with persistent fatigue, prolonged recovery times, or training plateaus may respond to the ATP-support pathway regardless of their testosterone status. This is the mechanism that explains why shilajit users often report subjective energy and recovery improvements even in cases where no testosterone change is measurable.

The Mitochondrial Effect — Why Energy Often Outperforms Testosterone as the Measurable Benefit#

The mitochondrial pathway tends to get treated as a secondary curiosity in shilajit research. It's worth taking more seriously.

A 2012 rat study using a chronic fatigue syndrome model found that shilajit significantly improved mitochondrial bioenergetics and modulated the HPA (hypothalamic-pituitary-adrenal) axis. The animals showed restored ATP production, improved ATP/AEC (adenylate energy charge) ratios, and behavioral recovery from fatigue compared to controls. The study used a stress model specifically designed to impair mitochondrial function — the same kind of physiological state that high-training-load athletes or chronically stressed men experience.

The practical implication: if your fatigue, poor recovery, or training plateau is partly driven by impaired mitochondrial energy production (a genuine possibility in men who train hard, sleep poorly, or are under sustained chronic stress), the DBP pathway in shilajit is directly targeting that bottleneck. The effect doesn't require testosterone optimization to deliver value.

This also explains why shilajit has genuine traditional use as an adaptogen for physical endurance and altitude performance — historically used by Himalayan populations to support physical capacity at altitude, where mitochondrial oxygen utilization is directly stressed. The DBP mitochondrial efficiency effect has a plausible mechanism for that use.